References
- Mamelak M. Gamma hydroxybutyrate; an endogenous regulator of energy and metabolism.Neurosci Behav Rev 1989; 13:187–198.
- Rosen M I, Pearsall H R, Woods S W, Kosten T R. Effects of gamma hydroxybutyric acid (GHB) in opioid dependent patients.J Subst Abuse Treat 1997; 14:149–154. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Vayer P, Mandel P, Maitre M. Gamma hydroxybutyrate: a possible neurotransmitter.Life Sci 1987; 41:1547–1557. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Maitre M, Rumigny J F, Cash C D, Mandel P. Subcellular distribution of gamma hydroxybutyrate binding sites in rat brain: principal localization in the synaptosomal fraction.Biochem Biophys Res Commun 1983; 110:262–265. [PUBMED], [INFOTRIEVE], [CROSSREF]
- National Institute on Drug Abuse. Conference highlights increasing GHB abuse.NIDA Notes 2001; 16.
- National Institute on Drug Abuse. Club Drugs. NIDA InfoFacts. 2000. Available at: http:///www.drugabuse.gov/Infofax/Clubdrugs.html Last accessed March 2004.
- Substance Abuse and Mental Health Service Administration. The DAWN Report. 2000. Available at: www.samhsa.gov Last accessed March 2004.
- Drug Abuse Warning Network. The DAWN Report. Club Drugs 2001 Update. Available at: http://www.samhsa.gov/oas/dawn.htm Last accessed March 2004.
- National Institute on Drug Abuse. Some facts about club drugs.NIDA Notes 2001. Available at: http://www.nida.nih.gov/ClubAlert/ClubDrugAlert.html Last accessed March 2004.
- Galloway G P, Frederick S L, Staggers F E, Gonzales M, Stalcup A, Smith D E. Gamma-hydroxybutarate: an emerging drug of abuse that causes physical dependence.Addiction 1997; 92:89–96. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Freese T E, Miotto K A, Reback C J. The effects and consequences of selected club drugs.J Subst Abuse Treat 2002; 23:151–156. [PUBMED], [INFOTRIEVE], [CROSSREF]
- McDaniel C H, Miotto K A. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.J Psychoact Drugs 2001; 33:143–149.
- Nimmerrichter A A, Walter H, Gutierrez-Lobos K E, Lesch O M. Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal.Alcohol Alcohol 2002; 37:67–73. [PUBMED], [INFOTRIEVE]
- Centers for Disease Control. Multistate outbreak of poisonings associated with the illicit use of gamma hydroxybutyrate.JAMA 1991; 265:447–448. [CROSSREF]
- Degenhardt L, Darke S, Dillon P. The prevalence and correlates of gamma-hydroxybutyrate (GHB) overdose among Australian users.Addiction 2003; 98:199–204. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Morbidity and Mortality Report. Multistate outbreak of poisonings associated with illicit use of gamma hydroxybutyrate.MMWR 1990; 39:861–862.
- Mamelak M, Scharf M B, Woods M. Treatment of narcolepsy with gamma hydroxybutyrate: a review of clinical and sleep laboratory findings.Sleep 1986; 9:285–289. [PUBMED], [INFOTRIEVE]
- Centers for Disease Control. Adverse events associated with ingestion of gamma-butyrolactone. Minnesota, New Mexico, Texas, 1998–1999.MMWR 1999; 48:137–140.
- Ingels M, Rangan C, Bellezo J, Clark R F. Coma and respiratory depression following the ingestion of GHB and its precursors: three cases.J Emerg Med 2000; 19:47–50., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Schneir A B, Ly B T, Clark R F. A case of withdrawal from the GHB precursors gamma butyrolactone and 1,4 butenadiol.J Emerg Med 2001; 21:31–33. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Camacho A, Matthews S C, Dimsdale J E. Use of GHB compounds by HIV positive individuals.Am J Addict. 2004; 13:120–127. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pedersen W, Skrondal A. Ecstasy and new patterns of drug use: a normal population study.Addiction 1999; 94:1695–1706. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Community Epidemiology Work Group. Epidemiologic trends in drug abuse. In Proceedings of the Community Epidemiology Work Group. Bethesda, MD: NIH Publication, National Institute on Drug Abuse, 2002.